Stockscreener 앱 받기
19.34
0.47%
0.09
시간 외 거래:
19.34
전일 마감가:
$19.25
열려 있는:
$19.34
하루 거래량:
261.44K
Relative Volume:
2.09
시가총액:
$588.09M
수익:
-
순이익/손실:
-
주가수익비율:
-
EPS:
-
순현금흐름:
-
1주 성능:
-1.02%
1개월 성능:
+0.47%
6개월 성능:
+11.86%
1년 성능:
+44.54%
1일 변동 폭
$19.26
$19.66
1주일 범위
$19.03
$19.95
52주 변동 폭
$13.01
$21.32
Abrdn Life Sciences Investors Stock (HQL) Company Profile
Compare HQL vs DNP, UTG, AADX, ADX, UTF
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
HQL
Abrdn Life Sciences Investors
|
19.34 | 585.35M | 0 | 0 | 0 | 0.00 |
DNP
Dnp Select Income Fund Inc
|
11.00 | 4.18B | 0 | 0 | 0 | 0.00 |
UTG
Reaves Utility Income Fund
|
39.53 | 3.69B | 0 | 0 | 0 | 0.00 |
AADX
Adams Diversified Equity Fund
|
18.68 | 3.08B | 522.09M | -24.84M | 0 | -0.1455 |
ADX
Adams Diversified Equity Fund
|
25.36 | 3.17B | 0 | 0 | 0 | 0.00 |
UTF
Cohen Steers Infrastructure Fund Inc
|
27.73 | 3.14B | 0 | 0 | 0 | 0.00 |
Abrdn Life Sciences Investors 주식(HQL)의 최신 뉴스
Short Interest in abrdn Life Sciences Investors (NYSE:HQL) Grows By 339.8% - MarketBeat
Price to sales forward of abrdn Healthcare Investors Shares of Beneficial Interest – NYSE:HQH - TradingView
Price to earnings forward of abrdn Healthcare Investors Shares of Beneficial Interest – NYSE:HQH - TradingView
abrdn Life Sciences Investors Shares of Beneficial Interest Revenue Breakdown – NYSE:HQL - TradingView
abrdn Life Sciences Investors (NYSE:HQL) Sees Large Volume IncreaseHere's Why - MarketBeat
abrdn Healthcare Investors (NYSE:HQH) Sees Strong Trading VolumeHere's Why - MarketBeat
Allspring Global Investments Holdings LLC Grows Position in abrdn Life Sciences Investors $HQL - MarketBeat
Director Chris Mahai Acquires Shares in abrdn Healthcare Investo - GuruFocus
Insider Buying: Chris Mahai Acquires Shares of abrdn Life Sciences Investors (HQL) - GuruFocus
Director Chris Mahai buys 527 abrdn Life Sciences (NYSE: HQL) shares - Stock Titan
abrdn Life Sciences Investors Director Mahai Chris LaVictoire acquires $10,497.84 in common shares - Bitget
abrdn Life Sciences Investors (NYSE:HQL) Hits New 52-Week HighStill a Buy? - MarketBeat
abrdn Life Sciences Investors (NYSE:HQL) Short Interest Update - MarketBeat
NYSE New 52-Week Highs And Lows - Moomoo
Fed Minutes Reveal Significant Disagreement on Interest Rate PathReturn On Equity - Bölüm Sonu Canavarı
abrdn Life Sciences Investors (HQL) Rallies 2.38% as Sector Sentiment ImprovesDividend Arbitrage - dars.gov.et
HQL Edges Higher: abrdn Life Sciences Investors Shares Climb 0.70%Time Weighted Price - dars.gov.et
THWabrdn World Healthcare Fund Website Traffic and Mobile Apps Usage - Finviz
abrdn Healthcare Opportunities Fund offers high... - Pluang
THQ: A Solid Healthcare Fund For 2026 (NYSE:THQ) - Seeking Alpha
Press Release: Aberdeen Investments U.S. Closed-End Funds Announce Distribution Payment Details - Moomoo
Aberdeen Investments U.S. Closed-End Funds Announce Distribution Payment Details - TradingView
abrdn Life Sciences Investors (HQL) Advances 0.83% as Life Sciences Sector Shows StrengthMFI Divergence - dars.gov.et
abrdn Healthcare Investors (HQH) Edges Higher: Testing Key Resistance Near $20.50Volatility Breakout Picks - newsline.com
abrdn Healthcare Investors (HQH) Advances 1.44% as Sector Fund Tests Key Resistance ZoneHidden Order - newsline.com
abrdn Healthcare Opportunities Fund (THQ) Edges Higher Amid Sector StabilityGap and Go - newsline.com
New abrdn Life Sciences (NYSE: HQL) director files initial Form 3 - Stock Titan
Mahai Chris LaVictoire joins abrdn Healthcare (HQH) as reporting insider - Stock Titan
Abrdn Life Sciences Investors Reports Earnings Results for the Half Year Ended March 31, 2026 - marketscreener.com
Abrdn Healthcare Investors Reports Earnings Results for the Half Year Ended March 31, 2026 - marketscreener.com
abrdn Healthcare Investors (HQH) Dips 2.74% as Sector Rotation Pressures the Closed-End FundConversion Trade - dars.gov.et
HQHabrdn Healthcare Investors Stock Price and Quote - Finviz
THQabrdn Healthcare Opportunities Fund Stock Price and Quote - Finviz
THQ Surges 1.69%: Healthcare Fund Breaks Above Key Support LevelsFactor Valuation - newsline.com
Aberdeen Investments U.S. Closed-End Funds Announce Results Of Annual Meeting Of Shareholders - Weekly Voice
ION closes the gap between trading and pipeline execution across North American gas markets with NatGasHub.com - Weekly Voice
ABERDEEN INVESTMENTS U.S. CLOSED-END FUNDS ANNOUNCE RESULTS OF A - GuruFocus
ABERDEEN INVESTMENTS U.S. CLOSED-END FUNDS ANNOUNCE RESULTS OF ANNUAL MEETING OF SHAREHOLDERS – Company Announcement - Financial Times
PWRL Stock Price and Chart — NASDAQ:PWRL - TradingView
abrdn Life Sciences Investors (HQL) Gains 0.92% as Momentum Builds Near Key ResistanceFlat Correction - dars.gov.et
abrdn Healthcare Investors (HQH) Slightly Lower as Shares Test Key Support LevelsWyckoff Accumulation - Newser
abrdn World Healthcare Fund Q1 2026 Commentary - Seeking Alpha
abrdn Life Sciences Investors (HQL) Edges Higher as Sector Rotations Lift Healthcare-Focused CEFEquity Put Call - Newser
abrdn Life Sciences Investors (HQL) Edges Higher, Approaching ResistancePrice Momentum Stocks - Newser
Abrdn Life Sciences Investors: - marketscreener.com
abrdn Life Sciences Investors Q1 2026 Commentary - Seeking Alpha
HQH: Growth Potential Limited But Portfolio Structure (NYSE:HQH) - Seeking Alpha
HQL: Attractive Outlook With Growth Of GLP-1 Market (NYSE:HQL) - Seeking Alpha
abrdn Life Sciences Investors Fund offers 12.6% yield at 8.49% NAV discount, ideal for income-focused investors. - Pluang
Abrdn Healthcare Opportunities Fund Q1 2026 Commentary (NYSE:THQ) - Seeking Alpha
Abrdn Healthcare Investors Q1 2026 Commentary (NYSE:HQH) - Seeking Alpha
Abrdn Life Sciences Investors (HQL) 재무 분석
Abrdn Life Sciences Investors (HQL)에 대한 금융 데이터가 없습니다. 더 많은 정보를 위해 다른 주식을 확인해보세요.
매출
순이익
현금흐름
주당 순 이익
0.00%
0.56%
자본화:
|
볼륨(24시간):